The effect of two phosphodiesterase inhibitors on bone healing in mandibular fractures (animal study in rats)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Despite advances in maxillofacial surgery, impaired bone healing remains a concern for surgical teams. Many studies have evaluated the effects of sildenafil and pentoxifylline on bone healing. However, their effects on healing of bone fractures have not been well investigated. This study aimed to assess the effects of the phosphodiesterase inhibitors sildenafil and pentoxifylline on healing of mandibular fractures in rats. Materials and Methods: A total of 60 rats were randomly divided into six groups of 10. Mandibular fracture was induced in all rats. After the surgi-cal procedure, group C1 received saline, group S1 received 10 mg/kg sildenafil and group P1 received 50 mg/kg pentoxifylline. The rats were sacri-ficed after 1 week. Groups C4, S4, and P4 received pharmaceutical therapy as in groups C1, S1, and P1 but were sacrificed after 4 weeks. The samples then underwent histological analysis. Results: The mean rate of bone healing of mandibular fractures in groups S1 and P1 was significantly higher than in group C1 at 1 week (P<0.001). The mean rate of bone healing of mandibular fractures in group P1 was higher than in group S1 at 1 week (P=0.04). The mean rate of bone healing of mandibular fractures in groups S4 (P=0.001) and P4 (P=0.004) was significantly higher than in group C4 at 4 weeks, but no significant difference was noted in the rate of healing between groups P4 and S4 (P=0.53).Conclusion: Sildenafil and pentoxifylline can be used as adjuncts to enhance bone healing in rats.
Abstract
Objectives: Despite advances in maxillofacial surgery, impaired bone healing remains a concern for surgical teams. Many studies have evaluated the effects of sildenafil and pentoxifylline on bone healing. However, their effects on healing of bone fractures have not been well investigated. This study aimed to assess the effects of the phosphodiesterase inhibitors sildenafil and pentoxifylline on healing of mandibular fractures in rats. Materials and Methods: A total of 60 rats were randomly divided into six groups of 10. Mandibular fracture was induced in all rats. After the surgi-cal procedure, group C1 received saline, group S1 received 10 mg/kg sildenafil and group P1 received 50 mg/kg pentoxifylline. The rats were sacri-ficed after 1 week. Groups C4, S4, and P4 received pharmaceutical therapy as in groups C1, S1, and P1 but were sacrificed after 4 weeks. The samples then underwent histological analysis. Results: The mean rate of bone healing of mandibular fractures in groups S1 and P1 was significantly higher than in group C1 at 1 week (P<0.001). The mean rate of bone healing of mandibular fractures in group P1 was higher than in group S1 at 1 week (P=0.04). The mean rate of bone healing of mandibular fractures in groups S4 (P=0.001) and P4 (P=0.004) was significantly higher than in group C4 at 4 weeks, but no significant difference was noted in the rate of healing between groups P4 and S4 (P=0.53).Conclusion: Sildenafil and pentoxifylline can be used as adjuncts to enhance bone healing in rats.
참고문헌 (50)
- Glória JCR, "Comparison of bite force with locking plates versus non-locking plates in the treatment of mandibular fractures : a meta-analysis", Int Arch Otorhinolaryngol, 22, pp.181~189 (2018)[DOI]
- Uçan MC, "Influence of caffeic acid phenethyl ester on bone healing in a rat model", J Int Med Res, 41, pp.1648~1654 (2013)[DOI]
- Fernández JR, "A threedimensional numerical simulation of mandible fracture reduction with screwed miniplates", J Biomech, 36, pp.329~337 (2003)[DOI]
- Durmuş K, "Histopathological evaluation of the effect of locally administered strontium on healing time in mandibular fractures: an experimental study", Adv Clin Exp Med, 26, pp.1063~1067 (2017)[DOI]
- Hausman MR, "Prevention of fracture healing in rats by an inhibitor of angiogenesis", Bone, 29, pp.560~564 (2001)[DOI]
- Dincel YM, "Biomechanical, histological, and radiological effects of different phosphodiesterase inhibitors on femoral fracture healing in rats", J Orthop Surg(Hong Kong), 26 (2018)[DOI]
- Hankenson KD, "Biological perspectives of delayed fracture healing", Injury, 45(Suppl 2), pp.S8~S15 (2014)[DOI]
- Cook JJ, "Healing in the new millennium:bone stimulators: an overview of where we've been and where we may be heading", Clin Podiatr Med Surg, 32, pp.45~59 (2015)[DOI]
- Chao EY, "Biophysical stimulation of bone fracture repair, regeneration and remodelling", Eur Cell Mater, 6, pp.72~84 (2003)[DOI]
- Massari L, "Pulsed electromagnetic fields and low intensity pulsed ultrasound in bone tissue", Clin Cases Miner Bone Metab, 6, pp.149~154 (2009)
- Perry AC, "Levofloxacin and trovafloxacin inhibition of experimental fracture-healing", Clin Orthop Relat Res, (414), pp.95~100 (2003)[DOI]
- Zandi M, "Evaluation of mandibular fracture healing in rats under zoledronate therapy : a histologic study", Injury, 48, pp.2683~2687 (2017)[DOI]
- Colnot C, "Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development", Dev Biol, 269, pp.55~69 (2004)[DOI]
- Lienau J, "CYR61(CCN1)protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability", J Orthop Res, 24, pp.254~262 (2006)[DOI]
- Keramaris NC, "Fracture vascularity and bone healing : a systematic review of the role of VEGF", Injury, 39(Suppl 2), pp.S45~S57 (2008)[DOI]
- Diwan AD, "Nitric oxide modulates fracture healing", J Bone Miner Res, 15, pp.342~351 (2000)[DOI]
- Baldik Y, "Bone healing regulated by nitric oxide: an experimental study in rats", Clin Orthop Relat Res, (404), pp.343~352 (2002)[DOI]
- Derici H, "Effect of sildenafil on wound healing : an experimental study", Langenbecks Arch Surg, 395, pp.713~718 (2010)[DOI]
- Histing T, "Sildenafil accelerates fracture healing in mice", J Orthop Res, 29, pp.867~873 (2011)[DOI]
- Vidavalur R, "Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor", Vascul Pharmacol, 45, pp.91~95 (2006)[DOI]
- Hart K, "Short-and long-term effects of sildenafil on skin flap survival in rats", Laryngoscope, 116, pp.522~528 (2006)[DOI]
- Das A, "Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling", J Biol Chem, 280, pp.12944~12955 (2005)[DOI]
- Essayan DM, "Cyclic nucleotide phosphodiesterases", J Allergy Clin Immunol, 108, pp.671~680 (2001)[DOI]
- Delanian S, "Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis", J Clin Oncol, 23, pp.8570~8579 (2005)[DOI]
- Ward A, "Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy", Drugs, 34, pp.50~97 (1987)[DOI]
- Bayat M, "Patents of pentoxifylline administration on some diseases and chronic wounds", Recent Pat Regen Med, 4, pp.137~143 (2014)[DOI]
- Vashghani Farahani MM, "Effect of pentoxifylline administration on an experimental rat model of femur fracture healing with intramedullary fixation", Iran Red Crescent Med J, 17, pp.e29513~ (2015)[DOI]
- Ghofrani HA, "Sildenafil : from angina to erectile dysfunction to pulmonary hypertension and beyond", Nat Rev Drug Discov, 5, pp.689~702 (2006)[DOI]
- Koneru S, "Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats : role of VEGF", angiopoietin-1, 2008, pp.12, 2651~2664
- Kinoshita T, "Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice", Bone, 27, pp.811~817 (2000)[DOI]
- Labib GS, "Osteogenic effect of locally applied Pentoxyfilline gel : in vitro and in vivo evaluations", Drug Deliv, 22, pp.1094~1102 (2015)[DOI]
- Kahenasa N, "Resolution of pain and complete healing of mandibular osteoradionecrosis using pentoxifylline and tocopherol : a case report", Oral Surg Oral Med Oral Pathol Oral Radiol, 113, pp.e18~e23 (2012)[DOI]
- Delanian S, "Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol : a phase II trial", Head Neck, 27, pp.114~123 (2005)[DOI]
- Aydin K, "Effect of pentoxifylline on fracture healing : an experimental study", Eklem Hastalik Cerrahisi, 22, pp.160~165 (2011)
- Clark JD, "The 1996 guide for the care and use of laboratory animals", ILAR J, 38, pp.41~48 (1997)[DOI]
- Schlundt C, "Macrophages in bone fracture healing: their essential role in endochondral ossification", Bone, 106, pp.78~89 (2018)[DOI]
- Rotter N, "Cartilage and bone tissue engineering for reconstructive head and neck surgery", Eur Arch Otorhinolaryngol, 262, pp.539~545 (2005)[DOI]
- Vega LG, "Reoperative mandibular trauma : management of posttraumatic mandibular deformities", Oral Maxillofac Surg Clin North Am, 23, pp.47~61 (2011)[DOI]
- Irkorucu O, "The effect of sildenafil on an animal model for ischemic colitis", Dig Dis Sci, 53, pp.1618~1623 (2008)[DOI]
- Atalay Y, "The effects of amlodipine and platelet rich plasma on bone healing in rats", Drug Des Devel Ther, 9, pp.1973~1981 (2015)[DOI]
- Anitua E, "The potential impact of the preparation rich in growth factors(PRGF)in different medical fields", Biomaterials, 28, pp.4551~4560 (2007)[DOI]
- Yaman F, "Phosphodiesterase-5 inhibitors may facilitate bone defect recovery", Eur Rev Med Pharmacol Sci, 15, pp.1301~1305 (2011)
- Rajkumar DS, "Comparative evaluation of enalapril and losartan in pharmacological correction of experimental osteoporosis and fractures of its background", J Osteoporos, 2013, pp.325693~ (2013)[DOI]
- Corbett SA, "Differential localisation, expression and activity of nitric oxide synthases", J Bone Joint Surg Br, 81, pp.531~537 (1999)[DOI]
- Si W, "CCN1", Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells, 2006, pp.26, 2955~2964
- Takami M, "Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE", RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways, 2005, pp.579, 832~838
- Horiuchi H, "Enhancement of recombinant human bone morphogenetic protein-2(rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline", J Bone Miner Metab, 22, pp.329~334 (2004)[DOI]
- Horiuchi H, "Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline", Bone, 28, pp.290~294 (2001)[DOI]
- Tsutsumimoto T, "A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4(BMP-4)-dependent differentiation of osteoprogenitor cells", Bone, 31, pp.396~401 (2002)[DOI]
- Gong Y, "Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling", Cell Death Dis, 5, pp.e1544~ (2014)[DOI]
